nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiotepa—breast cancer—ovarian cancer	0.295	1	CtDrD
Thiotepa—Alkylating Activity—Altretamine—ovarian cancer	0.282	0.465	CiPCiCtD
Thiotepa—Alkylating Activity—Chlorambucil—ovarian cancer	0.162	0.267	CiPCiCtD
Thiotepa—Alkylating Activity—Melphalan—ovarian cancer	0.162	0.267	CiPCiCtD
Thiotepa—CYP3A4—Topotecan—ovarian cancer	0.00914	0.271	CbGbCtD
Thiotepa—CYP2B6—Doxorubicin—ovarian cancer	0.00794	0.235	CbGbCtD
Thiotepa—CYP3A4—Vinorelbine—ovarian cancer	0.00644	0.191	CbGbCtD
Thiotepa—CYP3A4—Paclitaxel—ovarian cancer	0.00452	0.134	CbGbCtD
Thiotepa—CYP3A4—Docetaxel—ovarian cancer	0.00327	0.0969	CbGbCtD
Thiotepa—CYP3A4—Doxorubicin—ovarian cancer	0.00244	0.0722	CbGbCtD
Thiotepa—Alopecia—Docetaxel—ovarian cancer	3.51e-05	0.000542	CcSEcCtD
Thiotepa—Pruritus—Vinorelbine—ovarian cancer	3.5e-05	0.000541	CcSEcCtD
Thiotepa—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	3.48e-05	0.000539	CcSEcCtD
Thiotepa—Mental disorder—Docetaxel—ovarian cancer	3.48e-05	0.000538	CcSEcCtD
Thiotepa—Myalgia—Paclitaxel—ovarian cancer	3.47e-05	0.000537	CcSEcCtD
Thiotepa—Arthralgia—Paclitaxel—ovarian cancer	3.47e-05	0.000537	CcSEcCtD
Thiotepa—Anxiety—Paclitaxel—ovarian cancer	3.46e-05	0.000535	CcSEcCtD
Thiotepa—Erythema—Docetaxel—ovarian cancer	3.45e-05	0.000534	CcSEcCtD
Thiotepa—Malnutrition—Docetaxel—ovarian cancer	3.45e-05	0.000534	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	3.45e-05	0.000533	CcSEcCtD
Thiotepa—Nausea—Topotecan—ovarian cancer	3.43e-05	0.000531	CcSEcCtD
Thiotepa—Alanine aminotransferase increased—Epirubicin—ovarian cancer	3.41e-05	0.000528	CcSEcCtD
Thiotepa—Cardiac arrest—Doxorubicin—ovarian cancer	3.4e-05	0.000527	CcSEcCtD
Thiotepa—Diarrhoea—Vinorelbine—ovarian cancer	3.38e-05	0.000523	CcSEcCtD
Thiotepa—Ataxia—Doxorubicin—ovarian cancer	3.37e-05	0.000521	CcSEcCtD
Thiotepa—Nausea—Melphalan—ovarian cancer	3.36e-05	0.00052	CcSEcCtD
Thiotepa—Confusional state—Paclitaxel—ovarian cancer	3.35e-05	0.000519	CcSEcCtD
Thiotepa—Blood creatinine increased—Doxorubicin—ovarian cancer	3.35e-05	0.000519	CcSEcCtD
Thiotepa—Back pain—Docetaxel—ovarian cancer	3.34e-05	0.000517	CcSEcCtD
Thiotepa—Dehydration—Doxorubicin—ovarian cancer	3.33e-05	0.000515	CcSEcCtD
Thiotepa—Infection—Paclitaxel—ovarian cancer	3.3e-05	0.000511	CcSEcCtD
Thiotepa—Dizziness—Vinorelbine—ovarian cancer	3.27e-05	0.000506	CcSEcCtD
Thiotepa—Nervous system disorder—Paclitaxel—ovarian cancer	3.26e-05	0.000505	CcSEcCtD
Thiotepa—Thrombocytopenia—Paclitaxel—ovarian cancer	3.26e-05	0.000504	CcSEcCtD
Thiotepa—Tachycardia—Paclitaxel—ovarian cancer	3.25e-05	0.000502	CcSEcCtD
Thiotepa—Skin disorder—Paclitaxel—ovarian cancer	3.23e-05	0.0005	CcSEcCtD
Thiotepa—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	3.22e-05	0.000499	CcSEcCtD
Thiotepa—Anaemia—Docetaxel—ovarian cancer	3.19e-05	0.000494	CcSEcCtD
Thiotepa—Pancytopenia—Epirubicin—ovarian cancer	3.18e-05	0.000491	CcSEcCtD
Thiotepa—Anorexia—Paclitaxel—ovarian cancer	3.17e-05	0.00049	CcSEcCtD
Thiotepa—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	3.16e-05	0.000488	CcSEcCtD
Thiotepa—Vomiting—Vinorelbine—ovarian cancer	3.14e-05	0.000486	CcSEcCtD
Thiotepa—Dysuria—Epirubicin—ovarian cancer	3.13e-05	0.000484	CcSEcCtD
Thiotepa—Rash—Vinorelbine—ovarian cancer	3.12e-05	0.000482	CcSEcCtD
Thiotepa—Dermatitis—Vinorelbine—ovarian cancer	3.11e-05	0.000482	CcSEcCtD
Thiotepa—Headache—Vinorelbine—ovarian cancer	3.1e-05	0.000479	CcSEcCtD
Thiotepa—Leukopenia—Docetaxel—ovarian cancer	3.09e-05	0.000478	CcSEcCtD
Thiotepa—Weight increased—Epirubicin—ovarian cancer	3.04e-05	0.000471	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	3.03e-05	0.000469	CcSEcCtD
Thiotepa—Hyperglycaemia—Epirubicin—ovarian cancer	3.02e-05	0.000467	CcSEcCtD
Thiotepa—Cough—Docetaxel—ovarian cancer	3.01e-05	0.000466	CcSEcCtD
Thiotepa—Pneumonia—Epirubicin—ovarian cancer	3e-05	0.000464	CcSEcCtD
Thiotepa—Convulsion—Docetaxel—ovarian cancer	2.99e-05	0.000463	CcSEcCtD
Thiotepa—Paraesthesia—Paclitaxel—ovarian cancer	2.99e-05	0.000462	CcSEcCtD
Thiotepa—Hypertension—Docetaxel—ovarian cancer	2.98e-05	0.000461	CcSEcCtD
Thiotepa—Infestation NOS—Epirubicin—ovarian cancer	2.98e-05	0.000461	CcSEcCtD
Thiotepa—Infestation—Epirubicin—ovarian cancer	2.98e-05	0.000461	CcSEcCtD
Thiotepa—Somnolence—Paclitaxel—ovarian cancer	2.96e-05	0.000457	CcSEcCtD
Thiotepa—Arthralgia—Docetaxel—ovarian cancer	2.94e-05	0.000455	CcSEcCtD
Thiotepa—Myalgia—Docetaxel—ovarian cancer	2.94e-05	0.000455	CcSEcCtD
Thiotepa—Pancytopenia—Doxorubicin—ovarian cancer	2.94e-05	0.000454	CcSEcCtD
Thiotepa—Nausea—Vinorelbine—ovarian cancer	2.94e-05	0.000454	CcSEcCtD
Thiotepa—Renal failure—Epirubicin—ovarian cancer	2.93e-05	0.000453	CcSEcCtD
Thiotepa—Dyspepsia—Paclitaxel—ovarian cancer	2.93e-05	0.000453	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	2.92e-05	0.000452	CcSEcCtD
Thiotepa—Stomatitis—Epirubicin—ovarian cancer	2.91e-05	0.00045	CcSEcCtD
Thiotepa—Jaundice—Epirubicin—ovarian cancer	2.91e-05	0.00045	CcSEcCtD
Thiotepa—Conjunctivitis—Epirubicin—ovarian cancer	2.9e-05	0.000448	CcSEcCtD
Thiotepa—Dysuria—Doxorubicin—ovarian cancer	2.89e-05	0.000448	CcSEcCtD
Thiotepa—Decreased appetite—Paclitaxel—ovarian cancer	2.89e-05	0.000447	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Paclitaxel—ovarian cancer	2.87e-05	0.000444	CcSEcCtD
Thiotepa—Fatigue—Paclitaxel—ovarian cancer	2.87e-05	0.000444	CcSEcCtD
Thiotepa—Pain—Paclitaxel—ovarian cancer	2.84e-05	0.00044	CcSEcCtD
Thiotepa—Constipation—Paclitaxel—ovarian cancer	2.84e-05	0.00044	CcSEcCtD
Thiotepa—Haematuria—Epirubicin—ovarian cancer	2.84e-05	0.00044	CcSEcCtD
Thiotepa—Confusional state—Docetaxel—ovarian cancer	2.84e-05	0.00044	CcSEcCtD
Thiotepa—Hepatobiliary disease—Epirubicin—ovarian cancer	2.82e-05	0.000436	CcSEcCtD
Thiotepa—Weight increased—Doxorubicin—ovarian cancer	2.82e-05	0.000436	CcSEcCtD
Thiotepa—Epistaxis—Epirubicin—ovarian cancer	2.81e-05	0.000435	CcSEcCtD
Thiotepa—Infection—Docetaxel—ovarian cancer	2.8e-05	0.000433	CcSEcCtD
Thiotepa—Hyperglycaemia—Doxorubicin—ovarian cancer	2.79e-05	0.000432	CcSEcCtD
Thiotepa—Agranulocytosis—Epirubicin—ovarian cancer	2.78e-05	0.00043	CcSEcCtD
Thiotepa—Pneumonia—Doxorubicin—ovarian cancer	2.77e-05	0.000429	CcSEcCtD
Thiotepa—Nervous system disorder—Docetaxel—ovarian cancer	2.76e-05	0.000428	CcSEcCtD
Thiotepa—Thrombocytopenia—Docetaxel—ovarian cancer	2.76e-05	0.000427	CcSEcCtD
Thiotepa—Infestation NOS—Doxorubicin—ovarian cancer	2.76e-05	0.000427	CcSEcCtD
Thiotepa—Infestation—Doxorubicin—ovarian cancer	2.76e-05	0.000427	CcSEcCtD
Thiotepa—Tachycardia—Docetaxel—ovarian cancer	2.75e-05	0.000426	CcSEcCtD
Thiotepa—Feeling abnormal—Paclitaxel—ovarian cancer	2.74e-05	0.000424	CcSEcCtD
Thiotepa—Skin disorder—Docetaxel—ovarian cancer	2.74e-05	0.000424	CcSEcCtD
Thiotepa—Gastrointestinal pain—Paclitaxel—ovarian cancer	2.72e-05	0.000421	CcSEcCtD
Thiotepa—Renal failure—Doxorubicin—ovarian cancer	2.71e-05	0.000419	CcSEcCtD
Thiotepa—Haemoglobin—Epirubicin—ovarian cancer	2.69e-05	0.000416	CcSEcCtD
Thiotepa—Jaundice—Doxorubicin—ovarian cancer	2.69e-05	0.000416	CcSEcCtD
Thiotepa—Stomatitis—Doxorubicin—ovarian cancer	2.69e-05	0.000416	CcSEcCtD
Thiotepa—Anorexia—Docetaxel—ovarian cancer	2.69e-05	0.000416	CcSEcCtD
Thiotepa—Conjunctivitis—Doxorubicin—ovarian cancer	2.68e-05	0.000415	CcSEcCtD
Thiotepa—Haemorrhage—Epirubicin—ovarian cancer	2.68e-05	0.000414	CcSEcCtD
Thiotepa—Urinary tract disorder—Epirubicin—ovarian cancer	2.64e-05	0.000409	CcSEcCtD
Thiotepa—Urticaria—Paclitaxel—ovarian cancer	2.64e-05	0.000409	CcSEcCtD
Thiotepa—Haematuria—Doxorubicin—ovarian cancer	2.63e-05	0.000407	CcSEcCtD
Thiotepa—Connective tissue disorder—Epirubicin—ovarian cancer	2.63e-05	0.000407	CcSEcCtD
Thiotepa—Abdominal pain—Paclitaxel—ovarian cancer	2.63e-05	0.000407	CcSEcCtD
Thiotepa—Body temperature increased—Paclitaxel—ovarian cancer	2.63e-05	0.000407	CcSEcCtD
Thiotepa—Urethral disorder—Epirubicin—ovarian cancer	2.62e-05	0.000406	CcSEcCtD
Thiotepa—Hepatobiliary disease—Doxorubicin—ovarian cancer	2.61e-05	0.000404	CcSEcCtD
Thiotepa—Epistaxis—Doxorubicin—ovarian cancer	2.6e-05	0.000402	CcSEcCtD
Thiotepa—Agranulocytosis—Doxorubicin—ovarian cancer	2.57e-05	0.000398	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Docetaxel—ovarian cancer	2.57e-05	0.000397	CcSEcCtD
Thiotepa—Paraesthesia—Docetaxel—ovarian cancer	2.53e-05	0.000392	CcSEcCtD
Thiotepa—Somnolence—Docetaxel—ovarian cancer	2.51e-05	0.000388	CcSEcCtD
Thiotepa—Eye disorder—Epirubicin—ovarian cancer	2.5e-05	0.000387	CcSEcCtD
Thiotepa—Tinnitus—Epirubicin—ovarian cancer	2.5e-05	0.000386	CcSEcCtD
Thiotepa—Haemoglobin—Doxorubicin—ovarian cancer	2.49e-05	0.000385	CcSEcCtD
Thiotepa—Cardiac disorder—Epirubicin—ovarian cancer	2.48e-05	0.000384	CcSEcCtD
Thiotepa—Dyspepsia—Docetaxel—ovarian cancer	2.48e-05	0.000384	CcSEcCtD
Thiotepa—Haemorrhage—Doxorubicin—ovarian cancer	2.48e-05	0.000383	CcSEcCtD
Thiotepa—Decreased appetite—Docetaxel—ovarian cancer	2.45e-05	0.000379	CcSEcCtD
Thiotepa—Hypersensitivity—Paclitaxel—ovarian cancer	2.45e-05	0.000379	CcSEcCtD
Thiotepa—Urinary tract disorder—Doxorubicin—ovarian cancer	2.45e-05	0.000378	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Docetaxel—ovarian cancer	2.43e-05	0.000376	CcSEcCtD
Thiotepa—Connective tissue disorder—Doxorubicin—ovarian cancer	2.43e-05	0.000376	CcSEcCtD
Thiotepa—Fatigue—Docetaxel—ovarian cancer	2.43e-05	0.000376	CcSEcCtD
Thiotepa—Angiopathy—Epirubicin—ovarian cancer	2.43e-05	0.000376	CcSEcCtD
Thiotepa—Urethral disorder—Doxorubicin—ovarian cancer	2.43e-05	0.000376	CcSEcCtD
Thiotepa—Immune system disorder—Epirubicin—ovarian cancer	2.42e-05	0.000374	CcSEcCtD
Thiotepa—Mediastinal disorder—Epirubicin—ovarian cancer	2.41e-05	0.000373	CcSEcCtD
Thiotepa—Pain—Docetaxel—ovarian cancer	2.41e-05	0.000373	CcSEcCtD
Thiotepa—Constipation—Docetaxel—ovarian cancer	2.41e-05	0.000373	CcSEcCtD
Thiotepa—Chills—Epirubicin—ovarian cancer	2.4e-05	0.000371	CcSEcCtD
Thiotepa—Arrhythmia—Epirubicin—ovarian cancer	2.39e-05	0.00037	CcSEcCtD
Thiotepa—Asthenia—Paclitaxel—ovarian cancer	2.39e-05	0.000369	CcSEcCtD
Thiotepa—Alopecia—Epirubicin—ovarian cancer	2.36e-05	0.000366	CcSEcCtD
Thiotepa—Pruritus—Paclitaxel—ovarian cancer	2.35e-05	0.000364	CcSEcCtD
Thiotepa—Mental disorder—Epirubicin—ovarian cancer	2.34e-05	0.000363	CcSEcCtD
Thiotepa—Erythema—Epirubicin—ovarian cancer	2.33e-05	0.00036	CcSEcCtD
Thiotepa—Malnutrition—Epirubicin—ovarian cancer	2.33e-05	0.00036	CcSEcCtD
Thiotepa—Feeling abnormal—Docetaxel—ovarian cancer	2.32e-05	0.000359	CcSEcCtD
Thiotepa—Eye disorder—Doxorubicin—ovarian cancer	2.31e-05	0.000358	CcSEcCtD
Thiotepa—Tinnitus—Doxorubicin—ovarian cancer	2.31e-05	0.000357	CcSEcCtD
Thiotepa—Gastrointestinal pain—Docetaxel—ovarian cancer	2.31e-05	0.000357	CcSEcCtD
Thiotepa—Cardiac disorder—Doxorubicin—ovarian cancer	2.3e-05	0.000356	CcSEcCtD
Thiotepa—Tension—Epirubicin—ovarian cancer	2.29e-05	0.000354	CcSEcCtD
Thiotepa—Diarrhoea—Paclitaxel—ovarian cancer	2.28e-05	0.000352	CcSEcCtD
Thiotepa—Nervousness—Epirubicin—ovarian cancer	2.26e-05	0.00035	CcSEcCtD
Thiotepa—Back pain—Epirubicin—ovarian cancer	2.25e-05	0.000349	CcSEcCtD
Thiotepa—Angiopathy—Doxorubicin—ovarian cancer	2.25e-05	0.000348	CcSEcCtD
Thiotepa—Immune system disorder—Doxorubicin—ovarian cancer	2.24e-05	0.000346	CcSEcCtD
Thiotepa—Mediastinal disorder—Doxorubicin—ovarian cancer	2.23e-05	0.000345	CcSEcCtD
Thiotepa—Abdominal pain—Docetaxel—ovarian cancer	2.23e-05	0.000345	CcSEcCtD
Thiotepa—Body temperature increased—Docetaxel—ovarian cancer	2.23e-05	0.000345	CcSEcCtD
Thiotepa—Chills—Doxorubicin—ovarian cancer	2.22e-05	0.000344	CcSEcCtD
Thiotepa—Arrhythmia—Doxorubicin—ovarian cancer	2.21e-05	0.000342	CcSEcCtD
Thiotepa—Dizziness—Paclitaxel—ovarian cancer	2.2e-05	0.00034	CcSEcCtD
Thiotepa—Vision blurred—Epirubicin—ovarian cancer	2.2e-05	0.00034	CcSEcCtD
Thiotepa—Alopecia—Doxorubicin—ovarian cancer	2.19e-05	0.000338	CcSEcCtD
Thiotepa—Mental disorder—Doxorubicin—ovarian cancer	2.17e-05	0.000336	CcSEcCtD
Thiotepa—Erythema—Doxorubicin—ovarian cancer	2.16e-05	0.000333	CcSEcCtD
Thiotepa—Malnutrition—Doxorubicin—ovarian cancer	2.16e-05	0.000333	CcSEcCtD
Thiotepa—Anaemia—Epirubicin—ovarian cancer	2.15e-05	0.000333	CcSEcCtD
Thiotepa—Agitation—Epirubicin—ovarian cancer	2.14e-05	0.000331	CcSEcCtD
Thiotepa—Tension—Doxorubicin—ovarian cancer	2.12e-05	0.000327	CcSEcCtD
Thiotepa—Vomiting—Paclitaxel—ovarian cancer	2.11e-05	0.000327	CcSEcCtD
Thiotepa—Rash—Paclitaxel—ovarian cancer	2.1e-05	0.000324	CcSEcCtD
Thiotepa—Dermatitis—Paclitaxel—ovarian cancer	2.09e-05	0.000324	CcSEcCtD
Thiotepa—Nervousness—Doxorubicin—ovarian cancer	2.09e-05	0.000324	CcSEcCtD
Thiotepa—Leukopenia—Epirubicin—ovarian cancer	2.09e-05	0.000323	CcSEcCtD
Thiotepa—Back pain—Doxorubicin—ovarian cancer	2.09e-05	0.000323	CcSEcCtD
Thiotepa—Headache—Paclitaxel—ovarian cancer	2.08e-05	0.000322	CcSEcCtD
Thiotepa—Hypersensitivity—Docetaxel—ovarian cancer	2.08e-05	0.000321	CcSEcCtD
Thiotepa—Cough—Epirubicin—ovarian cancer	2.03e-05	0.000314	CcSEcCtD
Thiotepa—Vision blurred—Doxorubicin—ovarian cancer	2.03e-05	0.000314	CcSEcCtD
Thiotepa—Asthenia—Docetaxel—ovarian cancer	2.02e-05	0.000313	CcSEcCtD
Thiotepa—Convulsion—Epirubicin—ovarian cancer	2.02e-05	0.000312	CcSEcCtD
Thiotepa—Hypertension—Epirubicin—ovarian cancer	2.01e-05	0.000311	CcSEcCtD
Thiotepa—Pruritus—Docetaxel—ovarian cancer	1.99e-05	0.000309	CcSEcCtD
Thiotepa—Anaemia—Doxorubicin—ovarian cancer	1.99e-05	0.000308	CcSEcCtD
Thiotepa—Arthralgia—Epirubicin—ovarian cancer	1.98e-05	0.000307	CcSEcCtD
Thiotepa—Myalgia—Epirubicin—ovarian cancer	1.98e-05	0.000307	CcSEcCtD
Thiotepa—Agitation—Doxorubicin—ovarian cancer	1.98e-05	0.000306	CcSEcCtD
Thiotepa—Anxiety—Epirubicin—ovarian cancer	1.98e-05	0.000306	CcSEcCtD
Thiotepa—Nausea—Paclitaxel—ovarian cancer	1.98e-05	0.000306	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	1.97e-05	0.000305	CcSEcCtD
Thiotepa—Leukopenia—Doxorubicin—ovarian cancer	1.93e-05	0.000298	CcSEcCtD
Thiotepa—Diarrhoea—Docetaxel—ovarian cancer	1.93e-05	0.000298	CcSEcCtD
Thiotepa—Confusional state—Epirubicin—ovarian cancer	1.92e-05	0.000297	CcSEcCtD
Thiotepa—Infection—Epirubicin—ovarian cancer	1.89e-05	0.000292	CcSEcCtD
Thiotepa—Cough—Doxorubicin—ovarian cancer	1.88e-05	0.000291	CcSEcCtD
Thiotepa—Convulsion—Doxorubicin—ovarian cancer	1.87e-05	0.000289	CcSEcCtD
Thiotepa—Nervous system disorder—Epirubicin—ovarian cancer	1.86e-05	0.000288	CcSEcCtD
Thiotepa—Dizziness—Docetaxel—ovarian cancer	1.86e-05	0.000288	CcSEcCtD
Thiotepa—Thrombocytopenia—Epirubicin—ovarian cancer	1.86e-05	0.000288	CcSEcCtD
Thiotepa—Hypertension—Doxorubicin—ovarian cancer	1.86e-05	0.000288	CcSEcCtD
Thiotepa—Tachycardia—Epirubicin—ovarian cancer	1.86e-05	0.000287	CcSEcCtD
Thiotepa—Skin disorder—Epirubicin—ovarian cancer	1.85e-05	0.000286	CcSEcCtD
Thiotepa—Arthralgia—Doxorubicin—ovarian cancer	1.84e-05	0.000284	CcSEcCtD
Thiotepa—Myalgia—Doxorubicin—ovarian cancer	1.84e-05	0.000284	CcSEcCtD
Thiotepa—Anxiety—Doxorubicin—ovarian cancer	1.83e-05	0.000283	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	1.82e-05	0.000282	CcSEcCtD
Thiotepa—Anorexia—Epirubicin—ovarian cancer	1.81e-05	0.00028	CcSEcCtD
Thiotepa—Vomiting—Docetaxel—ovarian cancer	1.79e-05	0.000277	CcSEcCtD
Thiotepa—Rash—Docetaxel—ovarian cancer	1.78e-05	0.000275	CcSEcCtD
Thiotepa—Dermatitis—Docetaxel—ovarian cancer	1.78e-05	0.000275	CcSEcCtD
Thiotepa—Confusional state—Doxorubicin—ovarian cancer	1.77e-05	0.000274	CcSEcCtD
Thiotepa—Headache—Docetaxel—ovarian cancer	1.77e-05	0.000273	CcSEcCtD
Thiotepa—Infection—Doxorubicin—ovarian cancer	1.75e-05	0.00027	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Epirubicin—ovarian cancer	1.73e-05	0.000268	CcSEcCtD
Thiotepa—Nervous system disorder—Doxorubicin—ovarian cancer	1.73e-05	0.000267	CcSEcCtD
Thiotepa—Thrombocytopenia—Doxorubicin—ovarian cancer	1.72e-05	0.000266	CcSEcCtD
Thiotepa—Tachycardia—Doxorubicin—ovarian cancer	1.72e-05	0.000266	CcSEcCtD
Thiotepa—Skin disorder—Doxorubicin—ovarian cancer	1.71e-05	0.000264	CcSEcCtD
Thiotepa—Paraesthesia—Epirubicin—ovarian cancer	1.71e-05	0.000264	CcSEcCtD
Thiotepa—Somnolence—Epirubicin—ovarian cancer	1.69e-05	0.000261	CcSEcCtD
Thiotepa—Anorexia—Doxorubicin—ovarian cancer	1.68e-05	0.000259	CcSEcCtD
Thiotepa—Nausea—Docetaxel—ovarian cancer	1.67e-05	0.000259	CcSEcCtD
Thiotepa—Dyspepsia—Epirubicin—ovarian cancer	1.67e-05	0.000259	CcSEcCtD
Thiotepa—Decreased appetite—Epirubicin—ovarian cancer	1.65e-05	0.000256	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Epirubicin—ovarian cancer	1.64e-05	0.000254	CcSEcCtD
Thiotepa—Fatigue—Epirubicin—ovarian cancer	1.64e-05	0.000254	CcSEcCtD
Thiotepa—Constipation—Epirubicin—ovarian cancer	1.63e-05	0.000252	CcSEcCtD
Thiotepa—Pain—Epirubicin—ovarian cancer	1.63e-05	0.000252	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	1.6e-05	0.000248	CcSEcCtD
Thiotepa—Paraesthesia—Doxorubicin—ovarian cancer	1.58e-05	0.000244	CcSEcCtD
Thiotepa—Feeling abnormal—Epirubicin—ovarian cancer	1.57e-05	0.000242	CcSEcCtD
Thiotepa—Somnolence—Doxorubicin—ovarian cancer	1.56e-05	0.000242	CcSEcCtD
Thiotepa—Gastrointestinal pain—Epirubicin—ovarian cancer	1.55e-05	0.000241	CcSEcCtD
Thiotepa—Dyspepsia—Doxorubicin—ovarian cancer	1.55e-05	0.00024	CcSEcCtD
Thiotepa—Decreased appetite—Doxorubicin—ovarian cancer	1.53e-05	0.000237	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Doxorubicin—ovarian cancer	1.52e-05	0.000235	CcSEcCtD
Thiotepa—Fatigue—Doxorubicin—ovarian cancer	1.52e-05	0.000235	CcSEcCtD
Thiotepa—Urticaria—Epirubicin—ovarian cancer	1.51e-05	0.000234	CcSEcCtD
Thiotepa—Constipation—Doxorubicin—ovarian cancer	1.5e-05	0.000233	CcSEcCtD
Thiotepa—Pain—Doxorubicin—ovarian cancer	1.5e-05	0.000233	CcSEcCtD
Thiotepa—Abdominal pain—Epirubicin—ovarian cancer	1.5e-05	0.000233	CcSEcCtD
Thiotepa—Body temperature increased—Epirubicin—ovarian cancer	1.5e-05	0.000233	CcSEcCtD
Thiotepa—Feeling abnormal—Doxorubicin—ovarian cancer	1.45e-05	0.000224	CcSEcCtD
Thiotepa—Gastrointestinal pain—Doxorubicin—ovarian cancer	1.44e-05	0.000223	CcSEcCtD
Thiotepa—Hypersensitivity—Epirubicin—ovarian cancer	1.4e-05	0.000217	CcSEcCtD
Thiotepa—Urticaria—Doxorubicin—ovarian cancer	1.4e-05	0.000216	CcSEcCtD
Thiotepa—Body temperature increased—Doxorubicin—ovarian cancer	1.39e-05	0.000215	CcSEcCtD
Thiotepa—Abdominal pain—Doxorubicin—ovarian cancer	1.39e-05	0.000215	CcSEcCtD
Thiotepa—Asthenia—Epirubicin—ovarian cancer	1.36e-05	0.000211	CcSEcCtD
Thiotepa—Pruritus—Epirubicin—ovarian cancer	1.35e-05	0.000208	CcSEcCtD
Thiotepa—Diarrhoea—Epirubicin—ovarian cancer	1.3e-05	0.000201	CcSEcCtD
Thiotepa—Hypersensitivity—Doxorubicin—ovarian cancer	1.3e-05	0.000201	CcSEcCtD
Thiotepa—Asthenia—Doxorubicin—ovarian cancer	1.26e-05	0.000195	CcSEcCtD
Thiotepa—Dizziness—Epirubicin—ovarian cancer	1.26e-05	0.000195	CcSEcCtD
Thiotepa—Pruritus—Doxorubicin—ovarian cancer	1.24e-05	0.000193	CcSEcCtD
Thiotepa—Vomiting—Epirubicin—ovarian cancer	1.21e-05	0.000187	CcSEcCtD
Thiotepa—Diarrhoea—Doxorubicin—ovarian cancer	1.2e-05	0.000186	CcSEcCtD
Thiotepa—Rash—Epirubicin—ovarian cancer	1.2e-05	0.000185	CcSEcCtD
Thiotepa—Dermatitis—Epirubicin—ovarian cancer	1.2e-05	0.000185	CcSEcCtD
Thiotepa—Headache—Epirubicin—ovarian cancer	1.19e-05	0.000184	CcSEcCtD
Thiotepa—Dizziness—Doxorubicin—ovarian cancer	1.16e-05	0.00018	CcSEcCtD
Thiotepa—Nausea—Epirubicin—ovarian cancer	1.13e-05	0.000175	CcSEcCtD
Thiotepa—Vomiting—Doxorubicin—ovarian cancer	1.12e-05	0.000173	CcSEcCtD
Thiotepa—Rash—Doxorubicin—ovarian cancer	1.11e-05	0.000172	CcSEcCtD
Thiotepa—Dermatitis—Doxorubicin—ovarian cancer	1.11e-05	0.000171	CcSEcCtD
Thiotepa—Headache—Doxorubicin—ovarian cancer	1.1e-05	0.00017	CcSEcCtD
Thiotepa—Nausea—Doxorubicin—ovarian cancer	1.04e-05	0.000162	CcSEcCtD
